NASDAQ:MDRX - Allscripts Healthcare Solutions Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$12.70 +0.07 (+0.55 %)
(As of 05/25/2018 04:00 PM ET)
Previous Close$12.63
Today's Range$12.62 - $12.79
52-Week Range$10.78 - $16.13
Volume706,000 shs
Average Volume2.00 million shs
Market Capitalization$2.24 billion
P/E Ratio27.02
Dividend YieldN/A
Beta1.24

About Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare Solutions logoAllscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. The company's Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services. Its Population Health segment offers health management and coordinated care solutions that enable hospitals, health systems, accountable care organizations, and other care facilities to connect, transition, analyze, and coordinate care across the entire care community. The company's Netsmart segment operates in and provides software and technology solutions to the health and human services, and post-acute sectors of health care. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Receive MDRX News and Ratings via Email

Sign-up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Computer integrated systems design
Sub-IndustryHealth Care Technology
SectorMedical
SymbolNASDAQ:MDRX
CUSIP01988P10
Phone312-506-1200

Debt

Debt-to-Equity Ratio1.53
Current Ratio1.02
Quick Ratio1.02

Price-To-Earnings

Trailing P/E Ratio27.02
Forward P/E Ratio22.68
P/E Growth1.66

Sales & Book Value

Annual Sales$1.81 billion
Price / Sales1.25
Cash Flow$1.6979 per share
Price / Cash7.48
Book Value$6.24 per share
Price / Book2.04

Profitability

EPS (Most Recent Fiscal Year)$0.47
Net Income$-152,600,000.00
Net Margins-11.34%
Return on Equity7.80%
Return on Assets2.20%

Miscellaneous

Employees8,900
Outstanding Shares177,950,000

Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) announced its quarterly earnings data on Thursday, May, 3rd. The software maker reported $0.16 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by $0.01. The software maker had revenue of $518.60 million for the quarter, compared to analysts' expectations of $527.34 million. Allscripts Healthcare Solutions had a negative net margin of 11.34% and a positive return on equity of 7.80%. The firm's revenue was up 24.9% on a year-over-year basis. During the same period in the prior year, the company posted $0.13 EPS. View Allscripts Healthcare Solutions' Earnings History.

When is Allscripts Healthcare Solutions' next earnings date?

Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for Allscripts Healthcare Solutions.

What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?

Allscripts Healthcare Solutions updated its FY18 earnings guidance on Thursday, May, 3rd. The company provided EPS guidance of $0.72-0.82 for the period, compared to the Thomson Reuters consensus estimate of $0.77. The company issued revenue guidance of $2.15-2.25 billion, compared to the consensus revenue estimate of $2.19 billion.

What price target have analysts set for MDRX?

17 brokers have issued 1 year target prices for Allscripts Healthcare Solutions' stock. Their predictions range from $12.00 to $19.00. On average, they anticipate Allscripts Healthcare Solutions' share price to reach $16.1331 in the next twelve months. View Analyst Ratings for Allscripts Healthcare Solutions.

What are Wall Street analysts saying about Allscripts Healthcare Solutions stock?

Here are some recent quotes from research analysts about Allscripts Healthcare Solutions stock:
  • 1. Maxim Group analysts commented, "1Q18 bookings of $304M, up 6.3% y/y, was below our estimate of $315M, but relatively inline with consensus of $305M." (5/4/2018)
  • 2. Cantor Fitzgerald analysts commented, "1Q18 results. Non-GAAP revenue of $518.6 million (+25% y/y) was below consensus of $529 million and our estimate of $533 million. 1Q18 results included EIS revenue of $91 million, which was slightly below 4Q17. Non- GAAP Netsmart revenue was $83 million, representing 11% y/y growth. Non- GAAP gross margin was 47.3%, essentially unchanged from a year earlier. Non- GAAP EPS of $0.16 were in line with our estimate, but $0.01 below consensus. We are not too concerned about the slight miss relative to consensus." (5/3/2018)
  • 3. According to Zacks Investment Research, "Allscripts has had a favorable run on the bourses over the last year, trading above the broader industry. The company’s solid growth in U.S. Core Solutions and Services holds promise at the moment. Allscripts Sunrise electronic health record (EHR) platform and Revenue Cycle Management Services are likely to drive the company’s top line in the quarters to come. Also, Allscripts has a leading market share in inpatient and ambulatory settings. Allscripts announced a definitive agreement to buy Practice Fusion for $100 million in cash. However, the company’s continued reliance on mergers and acquisition activities poses substantial integration risks. Intensifying competition is a major dampener. The company’s products have a long sales cycle which involves intensive decision-making at different managerial levels. Allscripts also expects a modest increase in operating expenses to support business growth over the long haul." (1/25/2018)

Are investors shorting Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions saw a drop in short interest in the month of May. As of May 15th, there was short interest totalling 14,902,389 shares, a drop of 9.3% from the April 30th total of 16,428,172 shares. Based on an average daily trading volume, of 3,032,726 shares, the days-to-cover ratio is currently 4.9 days. Currently, 8.5% of the company's shares are short sold.

Who are some of Allscripts Healthcare Solutions' key competitors?

Who are Allscripts Healthcare Solutions' key executives?

Allscripts Healthcare Solutions' management team includes the folowing people:
  • Mr. Paul M. Black, CEO & Director (Age 60)
  • Mr. Richard J. Poulton, Pres (Age 53)
  • Mr. Dennis M. Olis, Chief Financial Officer (Age 55)
  • Mr. Brian P. Farley, Exec. VP, Gen. Counsel & Chief Admin. Officer (Age 48)
  • Ms. Lisa Khorey, Exec. VP & Chief Client Delivery Officer (Age 51)

Has Allscripts Healthcare Solutions been receiving favorable news coverage?

News stories about MDRX stock have been trending somewhat positive this week, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Allscripts Healthcare Solutions earned a news sentiment score of 0.17 on Accern's scale. They also assigned press coverage about the software maker an impact score of 46.36 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

Who are Allscripts Healthcare Solutions' major shareholders?

Allscripts Healthcare Solutions' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (5.66%), Iridian Asset Management LLC CT (4.02%), Fiduciary Management Inc. WI (3.92%), Fisher Asset Management LLC (2.92%), Silvercrest Asset Management Group LLC (2.49%) and Neuberger Berman Group LLC (1.79%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, James Hewitt, Paul Black and Richard J Poulton. View Institutional Ownership Trends for Allscripts Healthcare Solutions.

Which major investors are selling Allscripts Healthcare Solutions stock?

MDRX stock was sold by a variety of institutional investors in the last quarter, including Iridian Asset Management LLC CT, Dalton Greiner Hartman Maher & Co., Mesirow Financial Investment Management Equity Management, Monarch Partners Asset Management LLC, Sei Investments Co., Blue Harbour Group L.P., Victory Capital Management Inc. and Hsbc Holdings PLC. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Brian Farley, James Hewitt, Paul Black and Richard J Poulton. View Insider Buying and Selling for Allscripts Healthcare Solutions.

Which major investors are buying Allscripts Healthcare Solutions stock?

MDRX stock was bought by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Silvercrest Asset Management Group LLC, Fort Washington Investment Advisors Inc. OH, UBS Group AG, Federated Investors Inc. PA, Fiduciary Management Inc. WI, Wesbanco Bank Inc. and Amundi Pioneer Asset Management Inc.. View Insider Buying and Selling for Allscripts Healthcare Solutions.

How do I buy shares of Allscripts Healthcare Solutions?

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Allscripts Healthcare Solutions' stock price today?

One share of MDRX stock can currently be purchased for approximately $12.70.

How big of a company is Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions has a market capitalization of $2.24 billion and generates $1.81 billion in revenue each year. The software maker earns $-152,600,000.00 in net income (profit) each year or $0.47 on an earnings per share basis. Allscripts Healthcare Solutions employs 8,900 workers across the globe.

How can I contact Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 312-506-1200 or via email at [email protected]


MarketBeat Community Rating for Allscripts Healthcare Solutions (MDRX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  486 (Vote Outperform)
Underperform Votes:  476 (Vote Underperform)
Total Votes:  962
MarketBeat's community ratings are surveys of what our community members think about Allscripts Healthcare Solutions and other stocks. Vote "Outperform" if you believe MDRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDRX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Allscripts Healthcare Solutions (NASDAQ:MDRX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
17 Wall Street analysts have issued ratings and price targets for Allscripts Healthcare Solutions in the last 12 months. Their average twelve-month price target is $16.1331, suggesting that the stock has a possible upside of 27.03%. The high price target for MDRX is $19.00 and the low price target for MDRX is $12.00. There are currently 1 sell rating, 3 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.712.652.592.53
Ratings Breakdown: 1 Sell Rating(s)
3 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $16.1331$16.3438$15.9688$15.1250
Price Target Upside: 27.03% upside33.64% upside15.46% upside16.89% upside

Allscripts Healthcare Solutions (NASDAQ:MDRX) Consensus Price Target History

Price Target History for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare Solutions (NASDAQ:MDRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/4/2018Bank of AmericaLower Price TargetBuy ➝ Buy$17.00 ➝ $15.50HighView Rating Details
5/4/2018Maxim GroupReiterated RatingBuy$18.00HighView Rating Details
5/4/2018SunTrust BanksUpgradeHold ➝ Buy$10.78 ➝ $16.13HighView Rating Details
5/3/2018Cantor FitzgeraldReiterated RatingBuy$18.00MediumView Rating Details
4/24/2018JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$16.00HighView Rating Details
2/17/2018Wells Fargo & CoSet Price TargetBuy$19.00HighView Rating Details
1/18/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$17.50MediumView Rating Details
1/11/2018Royal Bank of CanadaSet Price TargetBuy$19.00HighView Rating Details
1/4/2018CitigroupInitiated CoverageBuyLowView Rating Details
11/3/2017Robert W. BairdBoost Price TargetOutperform$16.00 ➝ $17.00N/AView Rating Details
10/27/2017KeyCorpReiterated RatingHoldN/AView Rating Details
10/3/2017Dougherty & CoReiterated RatingBuy$15.00 ➝ $16.00LowView Rating Details
9/11/2017CowenUpgradeMarket Perform ➝ Outperform$13.00 ➝ $16.00HighView Rating Details
8/25/2017Jefferies GroupSet Price TargetBuy$17.00LowView Rating Details
8/7/2017Morgan StanleyBoost Price TargetUnderweight$11.00 ➝ $12.00LowView Rating Details
7/21/2017Piper Jaffray CompaniesReiterated RatingHold$14.00LowView Rating Details
6/19/2017Leerink SwannDowngradeOutperform ➝ Market Perform$15.00 ➝ $13.00MediumView Rating Details
3/24/2017Deutsche BankUpgradeHold ➝ Buy$12.50 ➝ $14.00LowView Rating Details
2/17/2017OppenheimerReiterated RatingHoldN/AView Rating Details
1/8/2017FBR & CoReiterated RatingHold$12.00N/AView Rating Details
1/3/2017Canaccord GenuityReiterated RatingBuy$17.00N/AView Rating Details
10/23/2016ArgusReiterated RatingBuy$19.00N/AView Rating Details
10/5/2016UBSInitiated CoverageBuy$17.00N/AView Rating Details
8/5/2016Goldman Sachs GroupBoost Price TargetNeutral$14.00 ➝ $16.00N/AView Rating Details
(Data available from 5/26/2016 forward)

Earnings

Allscripts Healthcare Solutions (NASDAQ:MDRX) Earnings History and Estimates Chart

Earnings by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare Solutions (NASDAQ:MDRX) Earnings Estimates

2018 EPS Consensus Estimate: $0.56
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$0.11$0.13$0.12
Q2 20183$0.13$0.14$0.13
Q3 20182$0.15$0.15$0.15
Q4 20182$0.16$0.16$0.16

Allscripts Healthcare Solutions (NASDAQ MDRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/1/2018$0.18N/AView Earnings Details
5/3/2018Q1 2018$0.17$0.16$527.34 million$518.60 millionViewN/AView Earnings Details
2/15/2018Q4 2017$0.18$0.18$524.05 million$547.00 millionViewListenView Earnings Details
11/2/2017Q3 2017$0.12$0.12$429.94 million$451.20 millionViewN/AView Earnings Details
8/3/2017Q2 2017$0.15$0.11$424.94 million$426.10 millionViewListenView Earnings Details
5/4/2017Q1 2017$0.09$0.10$415.20 million$415.00 millionViewListenView Earnings Details
2/16/2017Q4 2016$0.1530$0.14$424.11 million$425.40 millionViewListenView Earnings Details
11/3/2016Q3$0.15$0.14$414.92 million$392.40 millionViewListenView Earnings Details
8/4/2016Q2$0.14$0.14$403.13 million$386.50 millionViewListenView Earnings Details
5/5/2016Q1$0.12$0.13$348.51 million$346.00 millionViewListenView Earnings Details
2/18/2016Q4$0.13$0.13$357.91 million$345.60 millionViewListenView Earnings Details
11/5/2015Q315$0.12$0.13$354.67 million$355.00 millionViewListenView Earnings Details
8/4/2015Q215$0.11$0.12$347.13 million$351.70 millionViewListenView Earnings Details
5/7/2015Q115$0.09$0.08$344.73 million$335.00 millionViewListenView Earnings Details
2/26/2015Q414$0.09$0.09$358.10 million$343.00 millionViewListenView Earnings Details
11/6/2014Q314$0.10$0.06$353.00 million$348.00 millionViewListenView Earnings Details
8/7/2014Q214$0.09$0.09$353.12 million$351.30 millionViewListenView Earnings Details
5/8/2014Q114$0.07$0.07$347.98 billion$340.30 billionViewListenView Earnings Details
2/20/2014Q413$0.08$0.08$343.47 million$351.00 millionViewListenView Earnings Details
11/7/2013Q313$0.08$0.05$355.30 million$334.00 millionViewListenView Earnings Details
8/8/2013Q2 2013$0.11$0.09$360.00 million$344.80 millionViewListenView Earnings Details
5/9/2013Q1 2013$0.14$0.09$368.11 million$347.10 millionViewListenView Earnings Details
2/19/2013Q4 2012$0.21$0.16$367.07 million$367.70 millionViewListenView Earnings Details
11/8/2012Q312$0.22$0.23$376.97 million$361.00 millionViewN/AView Earnings Details
8/8/2012$0.18$0.16ViewN/AView Earnings Details
4/26/2012$0.24$0.12ViewN/AView Earnings Details
2/16/2012$0.25$0.25ViewN/AView Earnings Details
11/3/2011$0.22$0.25ViewN/AView Earnings Details
8/2/2011$0.21$0.22ViewN/AView Earnings Details
5/5/2011$0.20$0.21ViewN/AView Earnings Details
2/15/2011$0.18$0.20ViewN/AView Earnings Details
11/8/2010Q3 2010$0.16$0.17ViewN/AView Earnings Details
7/20/2010Q2 2010$0.15$0.15ViewN/AView Earnings Details
4/7/2010Q1 2010$0.14$0.14ViewN/AView Earnings Details
1/10/2010Q4 2009$0.13$0.14ViewN/AView Earnings Details
9/29/2009Q3 2009$0.13$0.14ViewN/AView Earnings Details
7/20/2009Q2 2009$0.14$0.15ViewN/AView Earnings Details
4/2/2009Q1 2009$0.12$0.14ViewN/AView Earnings Details
1/8/2009Q4 2008$0.12$0.14ViewN/AView Earnings Details
10/23/2008Q3 2008$0.13$0.13ViewN/AView Earnings Details
8/5/2008Q2 2008$0.09$0.11ViewN/AView Earnings Details
4/30/2008Q1 2008$0.10$0.07ViewN/AView Earnings Details
2/13/2008Q4 2007$0.12$0.14ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Allscripts Healthcare Solutions (NASDAQ:MDRX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Allscripts Healthcare Solutions (NASDAQ MDRX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.75%
Insider Trading History for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare Solutions (NASDAQ MDRX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/15/2018Richard J PoultonPresidentSell15,000$13.53$202,950.00505,920View SEC Filing  
3/14/2018Brian FarleyEVPSell5,000$13.73$68,650.00240,672View SEC Filing  
12/15/2017Richard J PoultonPresidentSell15,000$14.26$213,900.001,351,773View SEC Filing  
12/14/2017Brian FarleyEVPSell5,000$14.35$71,750.00191,607View SEC Filing  
12/1/2017James HewittSVPSell36,796$14.11$519,191.56181,766View SEC Filing  
9/15/2017Richard J. PoultonPresidentSell15,000$13.56$203,400.00View SEC Filing  
9/14/2017Brian FarleyEVPSell5,000$13.52$67,600.00196,607View SEC Filing  
9/14/2017Paul BlackCEOSell15,000$13.52$202,800.00View SEC Filing  
5/16/2017Richard J PoultonPresidentSell25,000$12.06$301,500.00412,488View SEC Filing  
3/23/2017Brian FarleySVPSell15,000$11.63$174,450.00217,861View SEC Filing  
9/15/2016James HewittSVPSell17,500$13.00$227,500.00158,104View SEC Filing  
9/15/2016Paul BlackCEOSell15,000$13.00$195,000.001,177,009View SEC Filing  
7/11/2016Dennis OlisSVPSell7,000$14.00$98,000.00210,887View SEC Filing  
7/1/2016James HewittSVPSell17,500$13.00$227,500.00175,604View SEC Filing  
6/13/2016Paul BlackCEOSell15,000$13.04$195,600.001,197,329View SEC Filing  
6/13/2016Richard J PoultonPresidentSell10,000$13.03$130,300.00343,813View SEC Filing  
4/7/2016Dennis OlisSVPSell25,000$14.00$350,000.00217,887View SEC Filing  
3/30/2016James HewittSVPSell17,500$13.31$232,925.00228,104View SEC Filing  
3/30/2016Paul BlackCEOSell15,000$13.31$199,650.001,224,939View SEC Filing  
3/14/2016Richard J PoultonPresidentSell5,000$12.85$64,250.00359,064View SEC Filing  
8/17/2015James HewittSVPSell70,000$14.17$991,900.00View SEC Filing  
12/12/2014Paul BlackCEOBuy6,500$11.51$74,815.00View SEC Filing  
11/18/2014Anita PramodaDirectorBuy2,017$12.25$24,708.25View SEC Filing  
11/13/2014Dennis ChookaszianDirectorBuy10,000$12.43$124,300.00View SEC Filing  
11/11/2014Dennis OlisSVPBuy4,400$11.26$49,544.00View SEC Filing  
11/11/2014Paul BlackCEOBuy22,180$11.26$249,746.80View SEC Filing  
11/11/2014Richard J PoultonCFOBuy4,500$11.26$50,670.00View SEC Filing  
11/11/2014Stuart L BascombDirectorBuy6,743$11.26$75,926.18View SEC Filing  
8/18/2014Michael KlaykoDirectorBuy3,500$14.41$50,435.00View SEC Filing  
3/13/2014Deborah SnowSVPSell14,740$18.75$276,375.0032,560View SEC Filing  
11/21/2013Deborah SnowSVPSell2,400$14.70$35,280.0033,655View SEC Filing  
9/9/2013Clifford B MeltzerEVPSell35,000$14.56$509,600.00View SEC Filing  
8/15/2013Michael KlaykoDirectorBuy10,000$14.80$148,000.0024,225View SEC Filing  
5/30/2013Deborah SnowSVPSell1,495$13.71$20,496.45View SEC Filing  
5/20/2013Stuart L BascombDirectorBuy3,701$14.02$51,888.02View SEC Filing  
5/15/2013Paul BlackCEOBuy7,120$14.02$99,822.40View SEC Filing  
5/14/2013Steve ShuteVPSell14,612$14.10$206,029.20View SEC Filing  
3/12/2013Paul BlackCEOBuy23,625$12.69$299,801.25View SEC Filing  
3/12/2013Stuart L BascombDirectorBuy10,000$12.64$126,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Allscripts Healthcare Solutions (NASDAQ MDRX) News Headlines

Source:
DateHeadline
Allscripts' iPro Anesthesia to be Administered by SingHealthAllscripts' iPro Anesthesia to be Administered by SingHealth
finance.yahoo.com - May 24 at 5:29 PM
Allscripts to deliver anesthesia solution across SingHealth healthcare institutionsAllscripts to deliver anesthesia solution across SingHealth healthcare institutions
finance.yahoo.com - May 24 at 8:29 AM
Allscripts Sunrise™ powers The Dudley Group NHS Foundation Trust to transform delivery of careAllscripts Sunrise™ powers The Dudley Group NHS Foundation Trust to transform delivery of care
finance.yahoo.com - May 23 at 8:28 AM
Allscripts Sunrise(TM) powers The Dudley Group NHS Foundation Trust to transform delivery of careAllscripts Sunrise(TM) powers The Dudley Group NHS Foundation Trust to transform delivery of care
finance.yahoo.com - May 23 at 8:28 AM
$535.20 Million in Sales Expected for Allscripts (MDRX) This Quarter$535.20 Million in Sales Expected for Allscripts (MDRX) This Quarter
www.americanbankingnews.com - May 23 at 2:58 AM
Allscripts (MDRX) versus Ribbon Communications (RBBN) Head to Head ComparisonAllscripts (MDRX) versus Ribbon Communications (RBBN) Head to Head Comparison
www.americanbankingnews.com - May 22 at 1:33 PM
$0.18 Earnings Per Share Expected for Allscripts (MDRX) This Quarter$0.18 Earnings Per Share Expected for Allscripts (MDRX) This Quarter
www.americanbankingnews.com - May 21 at 3:16 PM
Allscripts (MDRX) Upgraded by ValuEngine to HoldAllscripts (MDRX) Upgraded by ValuEngine to Hold
www.americanbankingnews.com - May 17 at 10:23 PM
Practice Fusion, an Allscripts company, to Show New Real-World Evidence (RWE) at the 23rd Annual International ...Practice Fusion, an Allscripts company, to Show New Real-World Evidence (RWE) at the 23rd Annual International ...
www.globenewswire.com - May 16 at 5:27 PM
Market Trends Toward New Normal in Dynavax Technologies, Synergy Resources, Allscripts Healthcare Solutions ...Market Trends Toward New Normal in Dynavax Technologies, Synergy Resources, Allscripts Healthcare Solutions ...
globenewswire.com - May 16 at 8:36 AM
Market Trends Toward New Normal in Dynavax Technologies, Synergy Resources, Allscripts Healthcare Solutions, Plug Power, GameStop, and Newfield Exploration — Emerging Consolidated Expectations, Analyst RatingsMarket Trends Toward New Normal in Dynavax Technologies, Synergy Resources, Allscripts Healthcare Solutions, Plug Power, GameStop, and Newfield Exploration — Emerging Consolidated Expectations, Analyst Ratings
finance.yahoo.com - May 16 at 8:36 AM
Allscripts (MDRX) Upgraded to Sell by BidaskClubAllscripts (MDRX) Upgraded to Sell by BidaskClub
www.americanbankingnews.com - May 15 at 12:37 AM
Allscripts To Acquire HealthGrid For Mobile Patient EngagementAllscripts To Acquire HealthGrid For Mobile Patient Engagement
seekingalpha.com - May 10 at 5:43 PM
Allscripts Expected to Post FY2019 Earnings of $0.71 Per Share (MDRX)Allscripts Expected to Post FY2019 Earnings of $0.71 Per Share (MDRX)
www.americanbankingnews.com - May 9 at 9:47 AM
Allscripts (MDRX) Downgraded by BidaskClubAllscripts (MDRX) Downgraded by BidaskClub
www.americanbankingnews.com - May 8 at 3:58 PM
Dougherty & Co Comments on Allscripts Q2 2018 Earnings (MDRX)Dougherty & Co Comments on Allscripts' Q2 2018 Earnings (MDRX)
www.americanbankingnews.com - May 8 at 5:52 AM
Allscripts (MDRX) Given Average Rating of "Buy" by AnalystsAllscripts (MDRX) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - May 7 at 7:24 PM
Allscripts (MDRX) Expected to Announce Quarterly Sales of $543.19 MillionAllscripts (MDRX) Expected to Announce Quarterly Sales of $543.19 Million
www.americanbankingnews.com - May 6 at 4:51 AM
Allscripts (MDRX) PT Lowered to $15.50Allscripts (MDRX) PT Lowered to $15.50
www.americanbankingnews.com - May 5 at 2:59 AM
Maxim Group Reiterates "Buy" Rating for Allscripts (MDRX)Maxim Group Reiterates "Buy" Rating for Allscripts (MDRX)
www.americanbankingnews.com - May 4 at 6:05 PM
Allscripts (MDRX) Raised to "Buy" at SunTrust BanksAllscripts (MDRX) Raised to "Buy" at SunTrust Banks
www.americanbankingnews.com - May 4 at 3:17 PM
BRIEF-Allscripts Healthcare To Expand Followmyhealth Patient Engagement Platform PortfolioBRIEF-Allscripts Healthcare To Expand Followmyhealth Patient Engagement Platform Portfolio
www.reuters.com - May 4 at 8:29 AM
BRIEF-Allscripts Healthcare Solutions Purchase Price For Health Grid Is $60 MillionBRIEF-Allscripts Healthcare Solutions Purchase Price For Health Grid Is $60 Million
www.reuters.com - May 4 at 8:29 AM
Edited Transcript of MDRX earnings conference call or presentation 3-May-18 8:30pm GMTEdited Transcript of MDRX earnings conference call or presentation 3-May-18 8:30pm GMT
finance.yahoo.com - May 4 at 8:29 AM
$0.17 EPS Expected for Allscripts (MDRX) This Quarter$0.17 EPS Expected for Allscripts (MDRX) This Quarter
www.americanbankingnews.com - May 4 at 5:16 AM
Allscripts (MDRX) Posts Quarterly  Earnings Results, Misses Estimates By $0.01 EPSAllscripts (MDRX) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS
www.americanbankingnews.com - May 3 at 10:28 PM
Allscripts (MDRX) Earns Buy Rating from Cantor FitzgeraldAllscripts (MDRX) Earns Buy Rating from Cantor Fitzgerald
www.americanbankingnews.com - May 3 at 10:12 PM
Allscripts (MDRX) Updates FY18 Earnings GuidanceAllscripts (MDRX) Updates FY18 Earnings Guidance
www.americanbankingnews.com - May 3 at 7:12 PM
BRIEF-Allscripts To Significantly Expand FollowMyHealth Patient Engagement Platform Portfolio Through Acquisition ...BRIEF-Allscripts To Significantly Expand FollowMyHealth Patient Engagement Platform Portfolio Through Acquisition ...
www.reuters.com - May 3 at 5:15 PM
BRIEF-Allscripts Healthcare Q1 GAAP Loss Per Share $0.22BRIEF-Allscripts Healthcare Q1 GAAP Loss Per Share $0.22
www.reuters.com - May 3 at 5:15 PM
Allscripts (MDRX) to Buy HealthGridAllscripts (MDRX) to Buy HealthGrid
www.streetinsider.com - May 3 at 5:15 PM
Allscripts Achieves Top Honors From Hospital Chains, IDNs and Networks for Integrated EHR, Interoperability ...Allscripts Achieves Top Honors From Hospital Chains, IDNs and Networks for Integrated EHR, Interoperability ...
www.prnewswire.com - May 3 at 5:15 PM
Allscripts to significantly expand FollowMyHealth® patient engagement platform portfolio with new, advanced capabilities through acquisition of HealthGridAllscripts to significantly expand FollowMyHealth® patient engagement platform portfolio with new, advanced capabilities through acquisition of HealthGrid
finance.yahoo.com - May 3 at 5:15 PM
AllScripts: 1Q Earnings SnapshotAllScripts: 1Q Earnings Snapshot
finance.yahoo.com - May 3 at 5:15 PM
Allscripts announces first quarter 2018 resultsAllscripts announces first quarter 2018 results
finance.yahoo.com - May 3 at 5:15 PM
Allscripts to buy HealthGridAllscripts to buy HealthGrid
seekingalpha.com - May 3 at 4:47 PM
Allscripts (MDRX) Set to Announce Earnings on WednesdayAllscripts (MDRX) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - April 25 at 3:52 AM
JPMorgan Chase Begins Coverage on Allscripts (MDRX)JPMorgan Chase Begins Coverage on Allscripts (MDRX)
www.americanbankingnews.com - April 24 at 8:55 AM
JPMorgan Assumes Allscripts (MDRX) at OverweightJPMorgan Assumes Allscripts (MDRX) at Overweight
www.streetinsider.com - April 24 at 8:28 AM
Technical Perspectives on Application Software Stocks -- 2U, Allscripts Healthcare Solutions, Alteryx, and ANSYSTechnical Perspectives on Application Software Stocks -- 2U, Allscripts Healthcare Solutions, Alteryx, and ANSYS
www.prnewswire.com - April 23 at 8:24 AM
 Analysts Expect Allscripts (MDRX) Will Announce Quarterly Sales of $532.66 Million Analysts Expect Allscripts (MDRX) Will Announce Quarterly Sales of $532.66 Million
www.americanbankingnews.com - April 19 at 4:57 AM
Zacks: Brokerages Anticipate Allscripts (MDRX) Will Post Earnings of $0.17 Per ShareZacks: Brokerages Anticipate Allscripts (MDRX) Will Post Earnings of $0.17 Per Share
www.americanbankingnews.com - April 17 at 1:12 AM
Allscripts (MDRX) Given Consensus Recommendation of "Hold" by AnalystsAllscripts (MDRX) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - April 12 at 8:12 PM
DIGITAL HEALTH BRIEFING: Google, AMA launch interoperability challenge — Doctor On Demand rolls out location ...DIGITAL HEALTH BRIEFING: Google, AMA launch interoperability challenge — Doctor On Demand rolls out location ...
www.businessinsider.com - April 12 at 8:56 AM
Short Interest in Allscripts (MDRX) Increases By 29.0%Short Interest in Allscripts (MDRX) Increases By 29.0%
www.americanbankingnews.com - April 12 at 2:17 AM
Allscripts (MDRX) Lifted to "Hold" at Zacks Investment ResearchAllscripts (MDRX) Lifted to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 11 at 6:45 PM
Allscripts to release first-quarter 2018 financial results May 3Allscripts to release first-quarter 2018 financial results May 3
finance.yahoo.com - April 9 at 5:11 PM
Dougherty & Co Reiterates Buy Rating for Allscripts (MDRX)Dougherty & Co Reiterates Buy Rating for Allscripts (MDRX)
www.americanbankingnews.com - April 8 at 10:08 AM
Cantor Fitzgerald Reiterates Buy Rating for Allscripts (MDRX)Cantor Fitzgerald Reiterates Buy Rating for Allscripts (MDRX)
www.americanbankingnews.com - April 5 at 1:57 PM
Allscripts (MDRX) Downgraded by TheStreetAllscripts (MDRX) Downgraded by TheStreet
www.americanbankingnews.com - April 4 at 12:49 PM

SEC Filings

Allscripts Healthcare Solutions (NASDAQ:MDRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Allscripts Healthcare Solutions (NASDAQ:MDRX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Allscripts Healthcare Solutions (NASDAQ MDRX) Stock Chart for Saturday, May, 26, 2018

Loading chart…

This page was last updated on 5/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.